{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001593899","name":"Atea Pharmaceuticals, Inc.","summary":"Atea Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on discovering, developing, and commercializing novel orally administered antivirals. Its lead program is the combination regimen of bemnifosbuvir and ruzasvir for hepatitis C virus (HCV) treatment, currently in Phase 3 trials (C-BEYOND and C-FORWARD). It is also developing AT-587, a potential first direct-acting antiviral for chronic hepatitis E virus (HEV) infection, targeting immunocompromised patients, with a Phase 1 study anticipated in mid-2026.","people":[],"products":[{"name":"Bemnifosbuvir + Ruzasvir","type":"platform","description":"Investigational pan-genotypic, protease inhibitor-free oral regimen for chronic HCV infection; in Phase 3 clinical trials C-BEYOND and C-FORWARD."},{"name":"AT-587","type":"platform","description":"Investigational novel double prodrug nucleotide analog targeting chronic HEV infection in immunocompromised patients; pre-clinical stage with Phase 1 planned mid-2026."}],"partnerships":[{"partner_name":"undisclosed licensor","partnership_type":"licensing","description":"Ruzasvir, the NS5A inhibitor, was in-licensed for use in combination with bemnifosbuvir for HCV treatment.","start_date":null}],"affiliations":[],"origin":{"leaf":"45e97c0d2b9e3a96f4bc283e0c925fbd0021280583ee9933f76866347c4011a9","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"21690cea8cd398f4e54cf8c1702b4b6151984131c56f8a82bf9a0c3ecc3f1dab","parent":"d5ad7e4326584e0f0230aea3ab79a6fdaf24a3ec989abdc92a6bce8990a9a4b5","source":"0001193125-26-094159","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":1,"hourly_limit":500,"remaining":499,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}